BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 25, 2009
View Archived Issues
Oxcarbazepine reduces pain in Parkinson's disease patients
Read More
CD40L gene therapy shows promise in urothelial bladder cancer trial
Read More
Calixa Therapeutics announces successful completion of phase I study of CXA-101
Read More
Endo completes acquisition of Indevus
Read More
Toyama and Eisai to conduct additional study for T-614 and resubmit NDA
Read More
Shire reviews Q4 activities and looks ahead to upcoming milestones
Read More
Novel histamine H3 receptor antagonists claimed in AstraZeneca patent
Read More
Ono Pharmaceutical prepares and tests novel prostanoid DP receptor antagonists
Read More
Advaxis updates phase I trial survival data for ADXS-11-001
Read More
Orexo announces phase IIa data on OX-914 in allergic rhinitis
Read More
Celsion receives orphan drug designation for ThermoDox in liver cancer
Read More
Epiphany Biosciences to file IND to study valomaciclovir adjunctive therapy in MS
Read More
Morphotek and Eisai commence FDA SPA phase III farletuzumab trial
Read More
Genfit acquires type 2 diabetes and obesity program from Merck Sante
Read More
Novel antiviral candidate for the treatment of chronic hepatitis C is discovered
Read More
Radius initiates phase IIa RAD-1901 trial in menopausal hot flashes
Read More
Rexahn receives FDA approval to begin phase II trials for Archexin in pancreatic cancer
Read More
Dual inhibitor of Fms/Kit described by Plexxikon for the treatment of autoimmune conditions
Read More
Avexa reaches 16-week evaluation point in phase III trial of apricitabine in HIV
Read More
WAY-262611 acts as a Wnt beta-catenin agonist, increases bone formation in osteoporosis model
Read More
PF-0419789, mutant B-Raf inhibitor, synthesized at Pfizer
Read More
ACT-077825 generally well tolerated, decreases blood pressure in first-in-human study
Read More
DSMB recommends continuation of phase III trial of Vical's Allovectin-7
Read More
Vantia presents update on preclinical and clinical development portfolios
Read More
Syndax Pharmaceuticals describes sirtuin modulators for cancer treatment
Read More
Lilly presents novel gamma-secretase inhibitors
Read More
Novel histamine H1 receptor antagonists described by GlaxoSmithKline
Read More